Valuation AstraZeneca PLC Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 10:22:36 2026-07-24 EDT			5-day change	1st Jan Change
149.85 ^EUR	+0.57%		+0.07%	-5.34%

07-24	European Stocks Close Higher Friday; Eurozone Private Sector Expands in July	MT
07-24	Stocks rise as oil price cools on peace talk hope	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	262,188	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-8.9%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	281,383	274,090	265,671
Change	-	12.57%	-0.25%	-1.74%	36.64%	-9.58%	-2.59%	-3.07%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	21.1x	18.5x	16x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.94x	4.3x	3.63x
PEG	-	0x	0.4x	1.6x	0.6x	0.9x	1.3x	1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.15x	3.93x	3.69x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.45x	4.1x	3.74x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.3x	11x	9.71x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.3x	11.7x	10.3x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	28x	20.8x	18.2x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.57%	4.81%	5.5%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.341	3.522	3.657
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.98%	2.08%	2.16%
EPS ²	0.08	2.11	3.81	4.5	6.54	8.012	9.129	10.56
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	41.7%	38.6%	34.6%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,205	66,777	71,088
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,853	24,915	27,358
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,135	23,384	25,673
Net income ¹	112	3,288	5,961	7,035	10,225	12,431	13,928	15,975
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,195	11,903	3,484
Reference price ²	117.51	135.16	135.02	131.05	185.60	169.04	169.04	169.04
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.39x	12.58x	26.43x	0.57%	1,057B
JOHNSON & JOHNSON	27.79x	6.35x	17.58x	2.07%	624B
ABBVIE INC.	33.47x	7.59x	15.59x	2.68%	454B
ROCHE HOLDING AG	20.98x	4.63x	11.4x	2.86%	341B
NOVARTIS AG	21.62x	5.7x	13.97x	2.82%	297B
NOVO NORDISK A/S	14.13x	5.26x	10.83x	3.54%	215B
AMGEN INC.	24.37x	6.41x	11.32x	2.71%	201B
GILEAD SCIENCES, INC.	-47.14x	5.65x	31.2x	2.52%	162B
PFIZER INC.	12.7x	3.11x	7.85x	6.9%	143B
Average	15.92x	6.36x	16.24x	2.96%	388.29B
Weighted average by Cap.	24.50x	7.95x	18.55x	2.18%